We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Novel Reagents Advance Research Into Parkinsons Disease and Sleep Disorders

Cells under a microscope.
BioPORTER® protein delivery reagent kit enables direct translocation of proteins into living cells. Credit: AMSBIO.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

In a recent blog post – AMSBIO describe how life science research groups are using their BioPORTER®, Detachin™, and SoluLyse™ reagents to make groundbreaking advances in Parkinson’s research, hypersomnia studies and eco-friendly microbial ester production.

 

These novel reagents empower research by enhancing the efficiency, accuracy, and reproducibility of scientific investigations.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

A collaborative effort led by Dr. Wenjing Wang at the University of Michigan and Dr. Xiaobo Mao of Johns Hopkins University School of Medicine has made exciting advances in the development of potential therapeutics for Parkinson’s disease. To determine the relationship between α-syn aggregation and PFFNB2 in mammalian cells, Dr. Wang and Dr. Mao used a BioPORTER® protein delivery reagent kit to enable easy transduction of α-syn preformed fibrils to HEK293T cells. BioPORTER® uses biocompatible polymers to encapsulate and protect proteins during delivery, ensuring stability and activity, and paving the way for more accurate and reproducible results.

 

Dr Andrew Jenkins and his team at the University of Saint Joseph are pioneers in repurposing compounds to address the debilitating effects of sleep disorders including hypersomnia. Focusing on eleven compounds previously identified as modulators of GABAA receptor brain activity to alleviate excessive sleepiness, Dr. Jenkins team used Detachin™ Cell Detachment Solution from AMSBIO to prepare cells for electrophysiological analysis. Cell detachment is a critical step in cell culture experiments. Using Detachin™, the University of Saint Joseph researchers were able to reliably produce high cell viability and functionality, reducing the risk of altered cell behavior due to harsh detachment methods.

 

Microbial production of short-chain esters offers an eco-friendly alternative to chemical synthesis, but low yields remain a challenge. To address this, Dr. Arul M. Varman at Arizona State University and Dr. Ryan Davis from Sandia National Laboratories used SoluLyse™ Bacterial Protein Extraction Reagent to simplify and accelerate the process of obtaining high-quality protein extracts from E. coli. Using this unique and efficient, yet gentle formulation – the research teams found SoluLyse™ to be a great asset in their protein research, ensuring efficient cell lysis without compromising protein integrity.

 

Dr Maja Petkovic, Business Unit Manager at AMSBIO commented “Replacing basic life science reagents with products like BioPORTER®, Detachin™, and SoluLyse™ can lead to significant improvements in your research outcomes. These reagents offer enhanced performance and convenience, allowing you to obtain more reliable and reproducible results.”